Reimbursed with a limitationOriginator productATC C10BA05

Atozet

Atozet is an originator product from Organon GmbH and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 55.00 to CHF 132.20 depending on the pack; the patient co-payment is 40 per cent plus the deductible.

Core data

Authorisation holder
Organon GmbH
ATC code
C10BA05
IT group
07.12 Blutlipidsenkende Mittel
Active substances
Ezetimibum, Atorvastatinum
Preparation type
Originator product
On the SL since
01/05/2017
Last price change
01/08/2022
Co-payment
40%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Atozet Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 10/10 mg30 StkCHF 36.41CHF 55.0001/05/2018B7680652230012
Filmtabl 10/10 mg90 StkCHF 109.26CHF 132.2001/05/2018B7680652230029
Filmtabl 10/20 mg30 StkCHF 36.41CHF 55.0001/05/2018B7680652230036
Filmtabl 10/20 mg90 StkCHF 109.26CHF 132.2001/05/2018B7680652230043
Filmtabl 10/40 mg30 StkCHF 36.41CHF 55.0001/05/2018B7680652230050
Filmtabl 10/40 mg90 StkCHF 109.26CHF 132.2001/05/2018B7680652230067
Filmtabl 10/80 mg30 StkCHF 36.41CHF 55.0001/05/2018B7680652230074
Filmtabl 10/80 mg90 StkCHF 109.26CHF 132.2001/05/2018B7680652230081

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/07/2026

Die Vergütung erfolgt bei:
 - Patienten mit hohem Risiko gemäss AGLA-Risikokategorie, die den LDL-Zielwert  - Patienten mit sehr hohem Risiko gemäss AGLA-Risikokategorie, die den LDL-Zielwert  - Patienten mit Statin-Intoleranz, d.h. Patienten, die bei Einnahme eines Statins nicht tolerierbare Muskelschmerzen und/oder messbare Muskelschwäche und/oder eine Erhöhung der Creatininkinase >5x des oberen Grenzwertes aufweisen. Vor der Verschreibung von ATOZET ist ein anderes Statin und, sofern dies nicht vertragen wird, Atorvastatin oder Rosuvastatin 5-10 mg 1-2x pro Woche auszuprobieren.

More preparations in this group

FAQ

Is Atozet covered by Swiss health insurance?

Yes, but only under conditions. Atozet is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Atozet cost in Switzerland?

The public price is the maximum price set by the FOPH and for Atozet ranges from CHF 55.00 to CHF 132.20 per pack. The ex-factory price ranges from CHF 36.41 to CHF 109.26. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com